Home > Research > Publications & Outputs > A multi-omics study of diagnostic markers and t...

Links

Text available via DOI:

View graph of relations

A multi-omics study of diagnostic markers and the unique inflammatory tumor micro-environment involved in tuberous sclerosis complex-related renal angiomyolipoma

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

A multi-omics study of diagnostic markers and the unique inflammatory tumor micro-environment involved in tuberous sclerosis complex-related renal angiomyolipoma. / Wang, Zhan; Xiaoyan, L.; Wenda, W. et al.
In: International Journal of Oncology, Vol. 61, No. 5, 132, 15.09.2022.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

Wang, Z, Xiaoyan, L, Wenda, W, Jing, W, Seery, S, Jiyu, X, Haidan, S, Yuncui, Y, Yang, Z, Xu, W, Zhangcheng, L, Yanan, L, Wei, S, Lulu, J & Yushi, Z 2022, 'A multi-omics study of diagnostic markers and the unique inflammatory tumor micro-environment involved in tuberous sclerosis complex-related renal angiomyolipoma', International Journal of Oncology, vol. 61, no. 5, 132. https://doi.org/10.3892/ijo.2022.5422

APA

Wang, Z., Xiaoyan, L., Wenda, W., Jing, W., Seery, S., Jiyu, X., Haidan, S., Yuncui, Y., Yang, Z., Xu, W., Zhangcheng, L., Yanan, L., Wei, S., Lulu, J., & Yushi, Z. (2022). A multi-omics study of diagnostic markers and the unique inflammatory tumor micro-environment involved in tuberous sclerosis complex-related renal angiomyolipoma. International Journal of Oncology, 61(5), Article 132. https://doi.org/10.3892/ijo.2022.5422

Vancouver

Wang Z, Xiaoyan L, Wenda W, Jing W, Seery S, Jiyu X et al. A multi-omics study of diagnostic markers and the unique inflammatory tumor micro-environment involved in tuberous sclerosis complex-related renal angiomyolipoma. International Journal of Oncology. 2022 Sept 15;61(5):132. doi: 10.3892/ijo.2022.5422

Author

Wang, Zhan ; Xiaoyan, L. ; Wenda, W. et al. / A multi-omics study of diagnostic markers and the unique inflammatory tumor micro-environment involved in tuberous sclerosis complex-related renal angiomyolipoma. In: International Journal of Oncology. 2022 ; Vol. 61, No. 5.

Bibtex

@article{e07251c2c856431e8933061a7affec5a,
title = "A multi-omics study of diagnostic markers and the unique inflammatory tumor micro-environment involved in tuberous sclerosis complex-related renal angiomyolipoma",
abstract = "Tuberous sclerosis complex (TSC) is a rare disease that threatens multiple organs in the human body. TSC-associated renal angiomyolipoma (TSC-RAML) has potentially life-threatening complications and a generally poor prognosis. The present study aimed to find plasma proteomic diagnostics and disease-associated markers, and explore the tumor microenvironment using multi-omics. To achieve this goal, the plasma proteomics as well as tissue proteomics, bulk and single-cell RNA transcriptome from patients with TSC-RAML were examined and analyzed. The results suggested that plasma proteins such as MMP9 and C-C motif chemokine ligand 5 were able to differentiate TSC-RAML from sporadic angiomyolipoma and renal cyst. A correlation analysis revealed that plasma proteomics were associated with lymphangioleiomyomatosis, TSC-RAML grading and whole-body disease burden. Tissue proteomics of participants with TSC-RAML revealed disturbed small molecule catabolic process, mitochondrial matrix component and actin binding function. Bulk and single-cell RNA sequencing suggested a greater number of tumor-like cells, fibroblasts and mono- nuclear macrophages within the tumor microenvironment. The above results indicated that TSC-RAML exhibited a characteristic and disease-associated plasma proteomic profile. The unique microenvironment, made up of fibroblasts and mono-macrophages, may promote tumorigenesis and TSC-RAML progression. {\textcopyright} 2022 Spandidos Publications. All rights reserved.",
keywords = "diagnostic markers, proteomics, RNA transcriptome, tuberous sclerosis complex, tumor microenvironment, UPLC-MS",
author = "Zhan Wang and L. Xiaoyan and W. Wenda and W. Jing and S. Seery and X. Jiyu and S. Haidan and Y. Yuncui and Z. Yang and W. Xu and L. Zhangcheng and L. Yanan and S. Wei and J. Lulu and Z. Yushi",
note = "Export Date: 2 November 2022",
year = "2022",
month = sep,
day = "15",
doi = "10.3892/ijo.2022.5422",
language = "English",
volume = "61",
journal = "International Journal of Oncology",
number = "5",

}

RIS

TY - JOUR

T1 - A multi-omics study of diagnostic markers and the unique inflammatory tumor micro-environment involved in tuberous sclerosis complex-related renal angiomyolipoma

AU - Wang, Zhan

AU - Xiaoyan, L.

AU - Wenda, W.

AU - Jing, W.

AU - Seery, S.

AU - Jiyu, X.

AU - Haidan, S.

AU - Yuncui, Y.

AU - Yang, Z.

AU - Xu, W.

AU - Zhangcheng, L.

AU - Yanan, L.

AU - Wei, S.

AU - Lulu, J.

AU - Yushi, Z.

N1 - Export Date: 2 November 2022

PY - 2022/9/15

Y1 - 2022/9/15

N2 - Tuberous sclerosis complex (TSC) is a rare disease that threatens multiple organs in the human body. TSC-associated renal angiomyolipoma (TSC-RAML) has potentially life-threatening complications and a generally poor prognosis. The present study aimed to find plasma proteomic diagnostics and disease-associated markers, and explore the tumor microenvironment using multi-omics. To achieve this goal, the plasma proteomics as well as tissue proteomics, bulk and single-cell RNA transcriptome from patients with TSC-RAML were examined and analyzed. The results suggested that plasma proteins such as MMP9 and C-C motif chemokine ligand 5 were able to differentiate TSC-RAML from sporadic angiomyolipoma and renal cyst. A correlation analysis revealed that plasma proteomics were associated with lymphangioleiomyomatosis, TSC-RAML grading and whole-body disease burden. Tissue proteomics of participants with TSC-RAML revealed disturbed small molecule catabolic process, mitochondrial matrix component and actin binding function. Bulk and single-cell RNA sequencing suggested a greater number of tumor-like cells, fibroblasts and mono- nuclear macrophages within the tumor microenvironment. The above results indicated that TSC-RAML exhibited a characteristic and disease-associated plasma proteomic profile. The unique microenvironment, made up of fibroblasts and mono-macrophages, may promote tumorigenesis and TSC-RAML progression. © 2022 Spandidos Publications. All rights reserved.

AB - Tuberous sclerosis complex (TSC) is a rare disease that threatens multiple organs in the human body. TSC-associated renal angiomyolipoma (TSC-RAML) has potentially life-threatening complications and a generally poor prognosis. The present study aimed to find plasma proteomic diagnostics and disease-associated markers, and explore the tumor microenvironment using multi-omics. To achieve this goal, the plasma proteomics as well as tissue proteomics, bulk and single-cell RNA transcriptome from patients with TSC-RAML were examined and analyzed. The results suggested that plasma proteins such as MMP9 and C-C motif chemokine ligand 5 were able to differentiate TSC-RAML from sporadic angiomyolipoma and renal cyst. A correlation analysis revealed that plasma proteomics were associated with lymphangioleiomyomatosis, TSC-RAML grading and whole-body disease burden. Tissue proteomics of participants with TSC-RAML revealed disturbed small molecule catabolic process, mitochondrial matrix component and actin binding function. Bulk and single-cell RNA sequencing suggested a greater number of tumor-like cells, fibroblasts and mono- nuclear macrophages within the tumor microenvironment. The above results indicated that TSC-RAML exhibited a characteristic and disease-associated plasma proteomic profile. The unique microenvironment, made up of fibroblasts and mono-macrophages, may promote tumorigenesis and TSC-RAML progression. © 2022 Spandidos Publications. All rights reserved.

KW - diagnostic markers

KW - proteomics

KW - RNA transcriptome

KW - tuberous sclerosis complex

KW - tumor microenvironment

KW - UPLC-MS

U2 - 10.3892/ijo.2022.5422

DO - 10.3892/ijo.2022.5422

M3 - Journal article

VL - 61

JO - International Journal of Oncology

JF - International Journal of Oncology

IS - 5

M1 - 132

ER -